Three Highly Anticipated Flagship Upgraded Vaccines Filing for Market Listing; Significant Breakthrough Achieved in the International Market
HONG KONG SAR -
Media OutReach Newswire - 28 March 2024 -
AIM Vaccine Co., Ltd. (the "Company", together with its subsidiaries,the "Group")is pleased to announce the results for the year ended 31 December...
Read more: AIM Vaccine Announces 2023 Annual Results